Rchr
J-GLOBAL ID:201901013758383628   Update date: May. 10, 2024

Ii Hiromi

Ii Hiromi
Affiliation and department:
Homepage URL  (1): http://labo.kyoto-phu.ac.jp/oncology/
Research field  (1): Tumor biology
Research keywords  (2): cancer cell metabolism ,  cancer research
Research theme for competitive and other funds  (5):
  • 2023 - 2026 GGCT阻害によるNotch制御機構の解明と膠芽腫幹細胞を標的する新規治療法の確立
  • 2022 - 2025 GGCTとxCTのダブル阻害によりフェロトーシスを増強する全く新しいがん治療戦略
  • 2020 - 2023 GGCTによる代謝変容が誘導する新規Hedgehog経路活性化機構の解明
  • 2018 - 2019 新規GGCT阻害剤を用いた新しいがん治療戦略の創生
  • 2014 - γ-グルタミルシクロトランスフェラーゼ(GGCT)を標的とした新規抗がん剤の開発
Papers (42):
  • Yumiko Saito, Keiko Taniguchi, Hiromi Ii, Mano Horinaka, Susumu Kageyama, Susumu Nakata, Osamu Ukimura, Toshiyuki Sakai. Identification of c-Met as a novel target of γ-glutamylcyclotransferase. Scientific reports. 2023. 13. 1. 11922-11922
  • Yukie Nohara, Keiko Taniguchi, Hiromi Ii, Shun Masuda, Hiroko Kawakami, Masakatsu Matsumoto, Yasunao Hattori, Susumu Kageyama, Toshiyuki Sakai, Susumu Nakata, et al. Development of an activity-based chemiluminogenic probe for γ-glutamylcyclotransferase. Organic & biomolecular chemistry. 2023
  • Kaito Ohta, Hiromi Ii, Chiami Moyama, Shota Ando, Hisanori Nambu, Susumu Nakata, Naoto Kojima. Thiophene Carboxamide Analogs with Long Alkyl Chains Comprising Ethylene Glycol Units Inhibit Glioblastoma Cell Proliferation by Activating AMPK. Journal of Medicinal Chemistry. 2023
  • 齋藤 友充子, 谷口 恵香, 飯居 宏美, 堀中 真野, 影山 進, 中田 晋, 浮村 理, 酒井 敏行. c-Met発現低下を介したγ-glutamylcyclotrasnferase(GGCT)阻害による前立腺がん細胞増殖抑制の新規分子機構の解明(Identification of c-Met as a novel target of gamma-glutamylcyclotrasnferase in a prostate cancer cell line). 日本泌尿器科学会総会. 2023. 110回. AOP09-07
  • Chiami Moyama, Mitsugu Fujita, Hitoshi Okamoto, Hiromi Ii, Susumu Nakata. Myb Repression Mediates Stat5b-knockdown-induced Apoptosis and Inhibits Proliferation of Glioblastoma Stem Cells. Cancer genomics & proteomics. 2023. 20. 2. 195-202
more...
MISC (86):
  • 大田海斗, 飯居宏美, 茂山千愛美, 安藤翔太, 岩崎宏樹, 南部寿則, 中田晋, 小島直人. N-トリエチレングリコール含有アルキル-3-カルボキサミドの合成と膠芽腫に対する抗腫瘍効果. 日本薬学会九州山口支部大会講演要旨集(CD-ROM). 2023. 40th
  • 飯居宏美, 近藤真帆, 伊藤公成, 中田晋. Suppression of Wnt pathway is involved in anticancer activity of GGCT knockdown in colorectal cancer cells. 日本癌学会学術総会抄録集(Web). 2023. 82nd
  • 山本夏菜, 山向千晶, 松下眞子, 橋本彩花, 野瀬梢, 茂山千愛美, 藤田貢, 飯居宏美, 中田晋. The regulation of GGCT and hedgehog ligands expression in a glioblastoma stem cell model induced by sh-TP53, EGFRvIII and NRasG12V. 日本薬学会年会要旨集(Web). 2023. 143rd
  • 野瀬梢, 森昌也, 茂山千愛美, 飯居宏美, 藤田貢, 中田晋. γ-glutamylcyclotransferase knockdown inhibits proliferation of glioblastoma stem cells. 日本癌学会学術総会抄録集(Web). 2023. 82nd
  • 大田海斗, 藤井真人, 茂山千愛美, 飯居宏美, 中田晋, 岩崎宏樹, 山下正行, 南部寿則, 小島直人. Synthesis and Antitumor Activity of Novel Analog of Acetogenin Thiophene Analog with Triethylene Glycol in place of THF Moiety. 日本薬学会年会要旨集(Web). 2023. 143rd
more...
Patents (2):
  • γ-グルタミルシクロトランスフェラーゼ(GGCT)の新規基質およびそれを用いたGGCT活性測定法
  • γ-グルタミルシクロトランスフェラーゼ阻害剤
Lectures and oral presentations  (5):
  • γグルタミルシクロトランスフェラーゼ阻害剤pro-GAはMCF7担癌マウスにおいて抗腫瘍効果を示す
    (日本薬学会年会要旨集 2022)
  • γ-グルタミルシクロトランスフェラーゼを標的とした新規抗がん剤開発
    (第77回日本癌学会学術総会 2018)
  • A novel prodrug of γ-glutamylcyclotransferase inhibitor has anti-proliferative activity in vitro and anti-cancer activity in vivo
    (20th international conference on medicinal chemistry & rational drugs 2018)
  • Development of a new anti-cancer drug that targets the novel cancer-related protein C7orf24
    (The 3rd International Symposium of Training Plan for Oncology Professionals 2015)
  • C7orf24阻害による新規細胞死機構の検討
    (第64回日本薬学会近畿支部総会・大会 2014)
Education (3):
  • 2005 - 2008 Kyoto Pharmaceutical University
  • 2003 - 2005 Kyoto Pharmaceutical University
  • 1999 - 2003 Kyoto Pharmaceutical University Pharmaceutical Sciences
Professional career (1):
  • 博士(薬学) (京都薬科大学)
Work history (2):
  • 2010/07 - 現在 Kyoto Pharmaceutical University Department of Clinical Oncology Assistant professor
  • 2008/10 - 2010/03 University of Washington Department of Chemistry and Biochemistry Postdoctoral fellow
Awards (2):
  • 2015/02 - The 3rd International Symposium of Training Plan for Oncology Professionals Best Presentation Award Development of a new anti-cancer drug that targets the novel cancer-related protein C7orf24.
  • 2007/10 - XVI International Symposium on Drug Affecting Lipid Metabolism Young Investigator Award Cytosolic phospholipase A2α promotes atherosclerotic lesions in mice
Association Membership(s) (2):
THE JAPANESE CANCER ASSOCIATION ,  THE PHARMACEUTICAL SOCIETY OF JAPAN
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page